Legend Biotech Corp 20-F for FY2024
Legend Biotech Corp (LEGN)
20-F
2025-03-11
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 20-F
Legend Biotech Corp filed this 20-F on March 11, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $627.24M
- up 120.0% from $285.14M a year earlier
- Net loss
- $177.03M
- compared with a net loss of $518.25M a year earlier
- Diluted EPS
- -$0.48
- compared with -$1.47 a year earlier